LEADER 05436nam 2200673Ia 450 001 996201971203316 005 20240418063415.0 010 $a1-281-32207-5 010 $a9786611322076 010 $a0-470-75082-0 010 $a0-470-75028-6 035 $a(CKB)1000000000408826 035 $a(EBL)351012 035 $a(OCoLC)437214018 035 $a(SSID)ssj0000123524 035 $a(PQKBManifestationID)11141263 035 $a(PQKBTitleCode)TC0000123524 035 $a(PQKBWorkID)10009039 035 $a(PQKB)11783528 035 $a(MiAaPQ)EBC351012 035 $a(Au-PeEL)EBL351012 035 $a(CaPaEBR)ebr10232980 035 $a(CaONFJC)MIL132207 035 $a(EXLCZ)991000000000408826 100 $a20051108d2006 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aClinical dilemmas in inflammatory bowel disease$b[electronic resource] /$fedited by Peter Irving, David Rampton, Fergus Shanahan 205 $a1st ed. 210 $aMalden, MA $cBlackwell Pub. Ltd$d2006 215 $a1 online resource (264 p.) 300 $aDescription based upon print version of record. 311 $a1-4051-3377-5 320 $aIncludes bibliographical references and index. 327 $aClinical Dilemmas in: Inflammatory Bowel Disease; Contents; List of Contributors; Preface; Part 1 Investigating IBD in the 21st Century; 1 Capsule endoscopy: do we need it?; 2 Pathology reports - pitfalls for the unwary; 3 Non-invasive diagnosis and assessment; 4 What is the best way to image perianal Crohn's disease?; 5 Surveillance colonoscopy in UC: alternatives and ways to improve outcome; 6 Abnormal liver tests - what should we do about them?; Part 2 Medical Treatment: Making the Most of What We've Got - 5-ASA drugs; 5-ASA drugs; 7 Is monitoring necessary? 327 $a8 Do they have a role in Crohn's disease?Steroids; 9 Steroids in Crohn's: are they obsolete?; Antibiotics for Crohn's disease; 10 Antibiotics: which, when, and for how long?; 11 M ycobacterium av ium paratuberculosis in Crohn's disease: player or spectator?; Immunomodulators; 12 TPMT testing: is it essential?; 13 6-Mercaptopurine or azathioprine?; 14 Thiopurines: how long should we use them for?; 15 Making the most of methotrexate; 16 Cyclosporine: balancing risk and benefit; Infliximab; 17 Contraindications - absolute or relative?; 18 How can we prevent tuberculosis? 327 $a19 Dealing with infusion reactions20 Use in ulcerative colitis; 21 Infliximab and surgery: health or hazard?; Nutritional therapy for Crohn's disease; 22 Nutritional therapy for Crohn's disease: is it for adults?; Part 3 Medical Treatment: What's Round the Corner?; 23 Trials and tribulations - interpreting clinical trials in IBD; 24 Genetics - clinical and therapeutic applications; 25 Probiotics - separating science from snakeoil; 26 Worms; 27 Smoking and nicotine - poison for Crohn's, potion for colitis?; 28 Heparin; 29 Leukocytapheresis: filtering out the facts 327 $a30 Appendectomy for ulcerative colitis - a therapeutic option?31 Biologic treatments in IBD; 32 Stem cell transplantation for IBD; 33 Complementary and alternative therapy - the way forward or a step back?; Part 4 Common Clinical Challenges: Beyond the Text Book; 34 Functional problems; 35 Psychological stress: something to worry about?; 36 Drugs to avoid; 37 NSAIDs and COX-2 selective agents: cause or cure of pain in IBD?; 38 Iron replacement - is it safe and effective?; 39 Hepatitis B and C viruses - how do they affect management of IBD?; 40 Pregnancy: what drugs can we use? 327 $a41 How to prevent growth failure in children42 Predicting outcome in severe UC; 43 Refractory proctitis; 44 CMV co-infection - does it matter?; 45 Treatment of oral Crohn's disease; 46 Pathophysiologic approach to treatment of diarrhea in Crohn's disease; 47 Short bowel; 48 Management of internal fistulae; 49 What is indeterminate colitis?; 50 Pouches for indeterminate colitis?; 51 Colitis-associated cancer: what's the risk to your patients?; 52 What to do with dysplasia, DALMs, and adenomas; Part 5 Managing IBD Outside the Gut; 53 Pyoderma gangrenosum 327 $a54 Arthritides - helping the joints without harming the gut 330 $aEvidence-based guidance to answer more than 60 controversial clinical questions on inflammatory bowel disease Clinical Dilemmas in Inflammatory Bowel Disease is a practical handbook providing quick but detailed answers to the questions and challenges that you are faced with daily in the clinical setting. Each short chapter addresses a different topic and provides evidence-based guidance on subjects ranging from optimising current management through to special management problems and novel treatments. This book is suitable for all medical professionals involved 606 $aInflammatory bowel diseases 606 $aInflammatory bowel diseases$xDecision making 615 0$aInflammatory bowel diseases. 615 0$aInflammatory bowel diseases$xDecision making. 676 $a616.344 701 $aIrving$b Peter$f1970-$0909420 701 $aRampton$b David$0457140 701 $aShanahan$b Fergus$0909421 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a996201971203316 996 $aClinical dilemmas in inflammatory bowel disease$92034779 997 $aUNISA